A detailed history of Qrg Capital Management, Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, Qrg Capital Management, Inc. holds 42,377 shares of EXAS stock, worth $2.68 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
42,377
Previous 37,243 13.79%
Holding current value
$2.68 Million
Previous $1.57 Billion 83.46%
% of portfolio
0.03%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$42.43 - $70.83 $217,835 - $363,641
5,134 Added 13.79%
42,377 $2.89 Billion
Q2 2024

Jul 12, 2024

BUY
$41.33 - $74.26 $85,553 - $153,718
2,070 Added 5.89%
37,243 $1.57 Billion
Q1 2024

May 07, 2024

BUY
$56.27 - $73.77 $166,109 - $217,769
2,952 Added 9.16%
35,173 $2.43 Billion
Q4 2023

Feb 07, 2024

SELL
$59.06 - $75.72 $29,057 - $37,254
-492 Reduced 1.5%
32,221 $2.38 Billion
Q3 2023

Nov 13, 2023

BUY
$65.94 - $99.04 $2.16 Million - $3.24 Million
32,713 New
32,713 $2.23 Billion

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $11.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Qrg Capital Management, Inc. Portfolio

Follow Qrg Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qrg Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Qrg Capital Management, Inc. with notifications on news.